Wh. Yong et al., CYST FLUID NB 70K CONCENTRATION AND LEUKOCYTE ESTERASE - 2 NEW MARKERS FOR DIFFERENTIATING PANCREATIC SEROUS TUMORS FROM PSEUDOCYSTS/, Pancreas, 10(4), 1995, pp. 342-346
Cystic lesions of the pancreas include inflammatory pseudocysts, serou
s cystadenomas, and mucinous tumors, some of which are malignant. Preo
perative clinical and radiological parameters are unreliable and may r
esult in incorrect diagnosis and inappropriate treatment. Cyst fluid a
nalysis for cytology, viscosity, carcinoembryonic antigen, CA 72-4, an
d CA 15-3 will distinguish mucinous from nonmucinous lesions and usual
ly help in determining malignancy. Currently, there is no reliable met
hod to differentiate inflammatory pseudocysts from serous cystadenomas
. This distinction is important because the treatment of these two les
ions is different; pseudocysts are either observed or drained, whereas
serous tumors are usually resected. The tumor marker NB/70K was measu
red in aspirated cyst fluid from 13 inflammatory pseudocysts and 11 se
rous cystadenomas by a commercial immunoassay. Leukocyte esterase was
measured using Chemstrip SG urine test strips and amylase and lipase o
n a routine chemistry analyzer. The cyst fluid NB/70K concentration wa
s significantly higher in pseudocysts (mean, 555 U/ml; range, 42-1,926
U/ml) than in serous cystadenomas (mean, 12 U/ml; range, 0-130 U/ml)
and this difference was significant (p < 0.0002). Leukocyte esterase w
as detected in 7 of 11 pseudocysts but was absent in 10 of 10 serous t
umors (p = 0.002). Amylase and lipase values were generally higher in
pseudocysts but these markers were unreliable due to marked outliers.
Cyst fluid NB/70K and leukocyte esterase are promising markers to help
differentiate pseudocysts from serous tumors on percutaneous aspirate
s. When combined with previously reported cyst fluid parameters (amyla
se, lipase, cytology, and amylase isoenzymes), these two cystic lesion
s can be reliably distinguished.